BRCA1 and breast carcinoma: In this study, 10 males with breast cancer were screened for mutations in BRCA1 and BRCA2. Besides, the patients were characterized for immunohistochemical features such as ER, PR, Her-2, and CK5/6 tissue tumor markers.